The UC Cancer Consortium
Five of the nation’s leading comprehensive cancer centers have joined forces to form the University of California Cancer Consortium (UCCC).
Each comprehensive cancer center treats all types of cancers in adults and children. Nearly half of the patients seen at a UC cancer center have late-stage cancers. These include patients diagnosed for the first time at a UC cancer center, as well as patients diagnosed elsewhere and referred by physicians to UC for specialized care. Cancer centers that achieve the National Cancer Institute (NCI) comprehensive cancer center designation frequently see patients with rare and difficult cancers who cannot be treated in other hospitals due to a lack of specific expertise or clinical trials involving the latest experimental drugs.
The five NCI-designated comprehensive cancer centers of the University of California bring many of the world’s top experts together for ground-breaking research, clinical trials and advanced patient care treatments. Combined, the UC Cancer Consortium administers more than a thousand clinical trials annually, connects more than tens of thousands of patients to the newest, most innovative therapies available, and works to accelerate the most promising therapies forward toward federal approval.
Collectively, the Consortium’s cancer centers are the nation’s top recipient of research grants from the National Institutes of Health (NIH) and of cancer research grants from the NCI, and the UC is the largest university holder of U.S. biomedical patents.
Find a clinical trial occurring at University of California Health cancer centers
Use our Clinical Trial finder to see trials at all five of UCH's NCI-designated comprehensive cancer centers. Each trial lists its unique criteria for participation. If you believe you meet the eligibility criteria, you can contact the research team to express interest.